HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Docetaxel said to be highly effective and well tolerated in advanced head and neck cancer.

Authors
JournalOncology (Williston Park, N.Y.) (Oncology (Williston Park)) Vol. 10 Issue 3 Pg. 422 (Mar 1996) ISSN: 0890-9091 [Print] United States
PMID8820455 (Publication Type: News)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Docetaxel
  • Paclitaxel
Topics
  • Antineoplastic Agents, Phytogenic (adverse effects, therapeutic use)
  • Clinical Trials, Phase III as Topic
  • Docetaxel
  • Head and Neck Neoplasms (drug therapy)
  • Humans
  • Paclitaxel (adverse effects, analogs & derivatives, therapeutic use)
  • Taxoids
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: